SB-284851-BT is a chemical compound that serves as an inhibitor of BRD4, p38alpha, and BRDT, exhibiting varying degrees of affinity and inhibition for each. Specifically, it inhibits BRD4-BD1 with an IC50 value of 1.7 µM, p38alpha with a Kd of 0.47 nM, BRDT (1) with an IC50 value of 18 µM, and BRD4 (1) with an IC50 value of 3.7 µM. By targeting p38alpha, SB-284851-BT effectively reduces IL-8 production and, through inhibiting BRD4, down-regulates both the c-Myc and NF-kappaB gene pathways, crucial in cancer pathways. Additionally, SB-284851-BT is designed to combine with the bromine domain and extra terminal (BET) proteins.
Molekulargewicht:
443.52
CAS Nummer:
[219769-23-0]
Formel:
C26H26FN5O
Target-Kategorie:
Epigenetic Reader Domain|||Others|||p38 MAPK
T69815
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
